Study of the ENTact Septal Staple System for Tissue Approximation During Septoplasty

NCT ID: NCT00740480

Last Updated: 2009-08-25

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

25 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-04-30

Study Completion Date

2009-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this research study is to learn more about the ENTact™ Septal Staple System device performance and to collect information to support its premarket application.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The ENTact™ Staple System is a device that inserts a small staple or tack to hold mucosa (moist tissues) in place instead of using stitches. The staple gradually dissolves and does not need to be removed. This clinical study will evaluate:

* surgical performance of the ENTact Septal Staple System
* one week post op clinical evaluation of gross tissue appearance at implantation site(s)
* ENTact™ Septal Staple functionality based on maintained coaptation

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Nasal Septum

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Surgical

Adult population (ages 18-65) with clinically significant nasal septum deviation.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult patients, between the ages of 18 and 65 years, with a clinically significant deviation of the nasal septum
* Patient is able to provide a signed informed consent form
* Patient will agree to comply with all study related procedures
* Patient is not pregnant at this time. If patient is of child-bearing age and capable of bearing children, a pre-operative pregnancy test confirmation is required to show that patient is not pregnant on the day of surgery
* Patient does not plan on becoming pregnant and is not breast feeding during the course of the study

* Patients who have had previous septoplasty
* Patients with uncontrolled diabetes
* Presence of infection at the site
* Smokers and severe drug and alcohol abusers
* Patients with autoimmune disease deemed clinically significant by Principal Investigator
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

ENTrigue Surgical, Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

ENTrigue Surgical, Inc.

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Gabriele G Niederauer, Ph.D.

Role: STUDY_DIRECTOR

ENTrigue Surgical, Inc.

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Good Samaritan Hospital

Cincinnati, Ohio, United States

Site Status

Park Hudson Surgery Center

Bryan, Texas, United States

Site Status

Physician's Ambulatory Surgery Center IV

San Antonio, Texas, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CSA 2008-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.